The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells

Leukemia

Volumn 10, Issue 5, 1996, Pages 829-835

  Gruss, H J ^a,b   Scheffrahn, I ^a   Hubinger G ^a   Duyster, J ^a   Herrmann, F ^a  

^a UNIVERSITY OF ULM   (Germany)

^b NONE   (Germany)

Author keywords

CD30L; CD40L; CD54; Hodgkin's disease; sCD54

Indexed keywords

CD30 ANTIGEN; CD40 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; MEMBRANE ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; REED STERNBERG CELL;

EID: 0029941063     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991; 9: 27-66.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm. Cell 1994; 76: 301-314.
3. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
4. Lub M, van Kooyk Y, Figdor CC. Ins and outs of LFA-1. Immunol Today 1995; 16: 479-483.
5. Maio M, Del Vecchio L. Expression and functional role of CD54/intercellular adhesion molecule-1 (ICAM-1) on human blood cells. Leuk Lymphoma 1992; 8: 23-33.
6. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Meduzzi VJ. Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 1988; 141: 1665-1669.
7. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Croup. Blood 1994; 84: 1361-1392.
8. Kadin ME. Pathology of Hodgkin's disease. Curr Opin Oncol 1994; 6: 456-463.
9. Haluska FC, Brufsky AM, Canellos G. The cellular biology of the Reed-Sternberg cell. Blood 1994; 84: 1005-1019.
10. Cruss H-J Herrmann F, Drexler HC. Hodgkin's disease: a cytokine producing tumor. Crit Rev Oncogenesis 1994; 5: 23-88.
11. Sanders ME, Makgoba MW, Sussman EH, Luce CEG, Cossman J, Shaw S. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428. Cancer Res 1988; 48: 37-40.
12. Ruco LP, Pomponi D, Pigott R, Gearing AJ, Baiocchini A, Baroni CD. Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial cell adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease. Am I Pathol 1992; 140: 1337-1344.
13. Gruss HJ, Dölken G, Brach MA, Mertelsmann R, Herrmann F. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease, Leukemia 1993; 7: 1245-1249.
14. Pizzolo C, Vinante F, Nadali C et al. ICAM-1 tissue over-expression associated with increased serum levels of its soluble form in Hodgkin's disease. Br J Haematol 1993; 84: 161-162.
15. Pui C-H, Luo X, Evans W et al. Serum intercellular adhesion molecule-1 in childhood malignancy. Blood 1993; 82: 895-898.
16. Chilosi M, Pizzolo G. Biopathologic features of Hodgkin's disease. Leuk Lymphoma 1995; 16: 385-395.
17. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-992.
18. Cruss H-J, Dower SK. TNF lignad superfamily: involvement in the pathology of malignant lymphomas. Blood 1995; 85: 3378-3404.
19. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993; 9: 1-25.
20. Spriggs MK, Armitage RJ, Strockbine L et al. Recombinant human CD40 ligand stimulates B cell proliferation and Immunoglobulin E secretion. J Exp Med 1992; 176: 1543-1550.
21. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging familv of cytokines with homology to TNF. Cell 1993; 73: 1349-1360.
22. Alderson MR, Smith CA, Tough TW et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 1994; 24: 2219-2227.
23. Goodwin RG, Alderson MR, Smith CA et al Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993; 73: 447-456.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
25. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragmentation to high specific activity. Anal Biochem 1983; 132: 6-13.
26. Gruss H-I, Hirschstein D, Wright B et al. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 1994; 84: 2305-2314.
27. Gruss H-I, Ulrich D, Braddy S, Armitage RJ, Dower SK. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur I Immunol 1995; 25: 2083-2089.
28. Gruss H-I, Dölken G, Brach MA, Mertelsmann R, Herrmann F. The significance of serum levels of soluble 60 kDa receptors for tumor necrosis factor in patients with Hodgkin's disease. Leukemia 1993; 7: 1339-1343.
29. Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press; New York, 1992.
30. Mackiewicz A, Kushner I, Baumann H. Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. CRC Press: Boca Raton, 1993.
31. Gruss HJ, Brach MA, Drexler HG, Bonifer R. Mertelsmann RH, Herrmann F. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 1992; 52: 3353-3360.
32. Gruss H-J, Herrmann F. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control for CD304 lymphoid and lymphoma cells. Leuk Lymphoma 1995; 18: 179-184.
33. Barrett TB, Shu G, Clark EA. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 1991; 146: 1722-1729.
34. Gruss H-J, Hirschstein D, Alderson MR, Armitage RJ. Regulation of CD30 ligand expression on peripheral blood T cells: functional involvement in T-T cell interaction. J Immunol 1996 (in press).
35. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester. J Immunol 1991; 147: 2777-2786.
36. Eck SL, Perkins ND, Carr DP, Nabel GJ. Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-κB in vivo. Mol Cell Biol 1993; 13: 6530-6536.
37. Berberich I, Shu GL, Clark EA. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J Immunol 1994; 153: 4357-4366.
38. McDonald PP, Cassatella M, Bald A et al. CD30 ligation induces NF-κB activation in human T cell lienns. Eur J Immunol 1995; 25: 2870-2876.
39. Gruss H-J, Ulrich D, Dower SK, Herrmann F, Brach MA. Activation of Hodgkin cells via the CD30 receptor induces aulocrine secretion of II-6 engaging the NF-κB transcription factor. Blood 1996; 78: 2443-2449.
40. Gearing AJH, Newman W. Circulating adhesion molecules in disease, Immunol Today 1993; 14: 506-512.